This compound is an isotopically labeled active pharmaceutical ingredient where specific carbon and hydrogen atoms are replaced with deuterium and carbon-13. It is a derivative of a substituted benzofuran carboxylic acid, characterized by multiple oxygen-containing functional groups and a side chain with a carboxylic acid terminus.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1261432-16-9
JTZ-951 hydrochloride
pharmaceutical raw material
Enarodustat
pharmaceutical raw material
Manidipine dihydrochloride
pharmaceutical raw material
Rifaximin-d6 (Major)
pharmaceutical raw material
Mycophenolic acid
pharmaceutical raw material
Mycophenolate sodium
pharmaceutical raw material
Mycophenolic acid-d3
pharmaceutical raw material
AC1LCSQ4
research compound
6-[4-hydroxy-7-methyl-3-oxo-6-(trideuterio(113C)methoxy)-1H-2-benzofuran-5-yl]-4-methylhex-4-enoic acid
HPNSFSBZBAHARI-LBDFIVMYSA-N
[2H][13C]([2H])([2H])OC1=C(C(=C2C(=C1C)COC2=O)O)CC=C(C)CCC(=O)O